This inventor holds 1 USPTO granted patent. Top assignee: Instytut Farmaceutyczny. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Michal Chodyński: Innovator in Pharmaceutical Chemistry
Introduction
Michal Chodyński is a notable inventor based in Pruszków, Poland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of pure compounds for medical use. His work is characterized by a focus on innovative processes that enhance the quality and efficacy of pharmaceutical products.
Latest Patents
Chodyński holds a patent for a process titled "Process for preparation of pharmaceutically pure anhydrous calcipotriol." This patent outlines a method for producing pharmaceutical-grade anhydrous calcipotriol through a series of steps that involve dissolving crude calcipotriol, obtaining an intermediate product, and re-dissolving it in an anhydrous solvent. The process is designed to ensure the purity and effectiveness of the final product, which is crucial for its application in medical treatments.
Career Highlights
Chodyński is affiliated with the Pharmaceutical Institute, where he applies his expertise in pharmaceutical chemistry. His work has been instrumental in advancing methods for drug preparation, contributing to the overall improvement of pharmaceutical practices. His dedication to innovation in this field has earned him recognition among his peers.
Collaborations
Chodyński collaborates with esteemed colleagues such as Andrzej Kutner and Teresa Ryznar. These partnerships enhance the research and development efforts within the Pharmaceutical Institute, fostering an environment of innovation and shared knowledge.
Conclusion
In summary, Michal Chodyński is a prominent inventor whose work in pharmaceutical chemistry has led to significant advancements in the preparation of pure compounds. His contributions are vital to the ongoing development of effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile